The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: Top Peptide for Injury Recovery & Gut Health Support Orthopedic Use of BPC 157 Sports Med Review FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling